Date:October 02, 2012

Joseph Lubega, MD, MPH

Joseph Lubega, M.D., M.P.H.Assistant Professor
Department of Pediatrics
Section of Hematology-Oncology
Baylor College of Medicine

6701 Fannin Street, Suite 1510.00
Houston, TX 77030

Fax: 832-825-1453


About Joseph Lubega, MD, MPH

Dr. Joseph is a member of the Global Oncology Program, Lymphoma Program, and the Epidemiology Program. He is currently serving as the Medical Director for the Global HOPE Program in Uganda, the Director of the East Africa Pediatric Hematology/Oncology Fellowship Training Program, and Chair of the Pediatric East Africa Clinical Oncology Consortium (PEACOC). Lead by Dr. Joseph Lubega, the East Africa Pediatric Hematology/Oncology Fellowship Training Program’s initial outcomes resulting from this fellowship are substantial and include improved clinical outcomes for pediatric cancer patients at the Uganda Cancer Institute, including a significant increase in patient response to treatment and reduction in patient deaths.

Dr. Joseph Lubega received his medical degree from Makerere University in Kampala, Uganda. He trained in Internal Medicine, Surgery, and Pediatrics in the United Kingdom before relocating to the Newark Beth Israel Medical Centre in Newark, New Jersey to complete Residency in Pediatrics. He was recognized as Resident of the Year in Pediatrics in June 2011 at the Newark Beth Israel Medical Center where he was based out of the Children’s Hospital of New Jersey. His Fellowship in Pediatric Hematology-Oncology was completed at Baylor College of Medicine, where he was based at Texas Children’s Cancer and Hematology Centers. He received a Master of Science in Public Health degree in the division of Epidemiology at the University of Texas Health Science Center at Houston, School of Public Health and completed a NCI-sponsored training fellowship in Pediatric Cancer Epidemiology and Control.

He is board certified in general pediatrics by the American Academy of Pediatrics.


Dr. Lubega’s research interests focus on the mechanisms of malignant transformation of immune cells by infections (EBV, Herpes Viruses, HIV, Malaria, etc) and other immunological alterations that may result in lymphoma, histiocytosis and possibly leukemia. He is a zealous advocate for building capacity for pediatric cancer care and research in Africa.

Professional Organizations

Member, American Academy of Pediatrics (AAP)